Day Trading Reports
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Day Trading Reports

Politics

National Cancer Institute spends $218M per year on grants for ‘underrepresented’ groups: source

by admin February 24, 2025
February 24, 2025
National Cancer Institute spends $218M per year on grants for ‘underrepresented’ groups: source

A watchdog group focused on getting diversity, equity and inclusion (DEI) out of medicine found that the National Cancer Institute (NCI) is actively spending millions of grant dollars to boost the number of racial minorities in the cancer workforce. 

This funding, uncovered by the nonprofit watchdog Do No Harm, shows that $218 million in NCI grants for ‘underrepresented’ groups – mainly racial minorities – is actively dispersed by the NCI. Prior to President Donald Trump taking office, during the Biden administration, around 3% of the NCI’s total grant funding every year went to institutions so that they can hire more faculty members and scientists who are minorities, according to Do No Harm.

The revelation comes as Elon Musk’s DOGE puts a slew of funds related to DEI on the chopping block amid efforts to slim down government spending. Trump and fellow Republicans have pushed hard against DEI policies throughout the government in recent weeks, making the case that public programs should instead focus on meritocracy. 

Among the NCI’s DEI grants that remain active under Trump are two totaling more than $10.5 million, awarded to the Icahn School of Medicine at Mount Sinai. These grants support hiring initiatives aimed at ‘inclusive excellence’ and programs that promote advancing the careers of racial minorities.

One of the grant’s descriptions explicitly calls for the recruitment of 12 scientists from ‘underrepresented groups,’ while the other grant’s description includes, alongside its recruitment and hiring goals, a plan to ‘modify the Mount Sinai Health System Task Force To Address Racism Roadmap for Change with key strategies as the basis for an Icahn School of Medicine at Mount Sinai Roadmap for Inclusive Excellence.’ 

In a statement to Fox News Digital, Do No Harm Chairman Dr. Stanley Goldfarb said the NCI must ‘stop promoting a politically motivated DEI agenda.’

‘The National Cancer Institute has been taking advantage of taxpayers to push a DEI agenda on the medical field,’ Goldfarb said. ‘They dole out $218 million each year for grants prioritizing ‘underrepresented’ in medicine, which has generally been defined as anyone from a racial minority group, except Asian Americans. The National Cancer Institute should not be rewarding racial discrimination with taxpayer money. Racial discrimination has no place in medicine.’

Under former President Joe Biden, the NCI’s website was filled with statements and sources about programs tied to DEI, but, following Trump’s executive order demanding an end to DEI in the federal government, much of that has come down. Fox News Digital reached out to the NCI to question whether it had any plans to terminate any of its active grants promoting DEI hiring, but did not receive a response by press time. 

Fox News Digital also inquired about the sub-agency’s Equity Council, established in 2021 under Biden, but did not receive a response. The council is a steering committee for the NCI’s equity and inclusion efforts.

DOGE claims it has already addressed hundreds of millions of taxpayer dollars in DEI-related contract cuts, including $350 million at the Department of Education. 

Last month, DOGE announced that taxpayers would see just over $1 billion in savings through the elimination of 104 DEI contracts.

This post appeared first on FOX NEWS

previous post
Tech 5: Intel Faces M&A Rumors, Apple Debuts New iPhone
next post
Trump announces Dan Bongino will be deputy director of the FBI

Related Posts

Trump urged to review UN immunity, lax visa...

April 4, 2025

Trump transportation secretary pick Sean Duffy to face...

January 28, 2025

Carney says Canada is not for sale, Trump...

May 7, 2025

WATCH: AOC leaves door open for 2028 presidential...

April 30, 2025

Trump’s ‘shock and awe’: Forget first 100 days,...

January 23, 2025

Iowa rep in swing district endorsed by group...

April 29, 2025

State Department says Ukraine ready to accept 30-day...

March 18, 2025

Trump executive order stands up presidential religious liberty...

May 2, 2025

Trump’s pick to lead NIH, Dr. Jay Bhattacharya,...

March 26, 2025

White House confirms who was appointed as acting...

February 26, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Forum Energy Metals and Global Uranium Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan

      January 31, 2025
    • 2

      Mega M&A: Rio Tinto-Glencore Merger Sparks Chatter

      January 28, 2025
    • 3

      Excellent 90% recoveries at Cork Tree Well & Board Update

      February 17, 2025
    • 4

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 5

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 6

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: daytradingreports.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 daytradingreports.com | All Rights Reserved